levocetirizine dihydrochloride- levocetirizine dihydrochloride tablet
preferred pharmaceuticals inc. - levocetirizine dihydrochloride (unii: sod6a38aga) (levocetirizine - unii:6u5ea9rt2o) - levocetirizine dihydrochloride 5 mg - levocetirizine dihydrochloride tablets are indicated for the relief of symptoms associated with perennial allergic rhinitis in children 6 months to 2 years of age. levocetirizine dihydrochloride tablets are indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months of age and older. the use of levocetirizine dihydrochloride tablets is contraindicated in: patients with known hypersensitivity to levocetirizine or any of the ingredients of levocetirizine dihydrochloride tablets, or to cetirizine. observed reactions range from urticaria to anaphylaxis [see adverse reactions (6.2) ]. patients with end-stage renal disease (clcr < 10 ml/min) and patients undergoing hemodialysis. children 6 months to 11 years of age with impaired renal function. pregnancy category b there are no adequate and well-controlled studies in pregnant women. because animal reproduction studies are not always predictive of human response, levocetirizine dihydrochloride
levocetirizine dihydrochloride- levocetirizine dihydrochloride tablet, film coated
micro labs limited - levocetirizine dihydrochloride (unii: sod6a38aga) (levocetirizine - unii:6u5ea9rt2o) - levocetirizine dihydrochloride 5 mg - levocetirizine dihydrochloride tablets are indicated for the relief of symptoms associated with perennial allergic rhinitis in children 6 years of age and older. levocetirizine dihydrochloride tablets are indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 years of age and older. the use of levocetirizine dihydrochloride tablets are contraindicated in: patients with known hypersensitivity to levocetirizine or any of the ingredients of levocetirizine dihydrochloride tablets, or to cetirizine. observed reactions range from urticaria to anaphylaxis [see adverse reactions ( 6.2) ]. patients with end-stage renal disease (cl cr < 10 ml/min) and patients undergoing hemodialysis children 6 months to 11 years of age with impaired renal function risk summary available data from published literature and postmarketing experience with levocetirizine use in pregnant women are insufficient
cetirizine galpharm, 10mg, film-coated tablets
galpharm healthcare limited - cetirizine hydrochloride - film-coated tablet - cetirizine hydrochloride 10 milligram(s) - antihistamines for systemic use
levocetirizine 5mg tablets
teva uk ltd - levocetirizine dihydrochloride - oral tablet - 5mg
levocetirizine 5mg tablets
a a h pharmaceuticals ltd - levocetirizine dihydrochloride - oral tablet - 5mg
levocetirizine 5mg tablets
alliance healthcare (distribution) ltd - levocetirizine dihydrochloride - oral tablet - 5mg
levocetirizine 5mg tablets
consilient health ltd - levocetirizine dihydrochloride - oral tablet - 5mg
levocetirizine 5mg tablets
phoenix healthcare distribution ltd - levocetirizine dihydrochloride - oral tablet - 5mg
cetirizine tablets film-coated
chanelle medical - cetirizine (cetirizine dihydrochloride) - tablets film-coated - 10mg
levocetirizine 5mg tablets
actavis uk ltd - levocetirizine dihydrochloride - oral tablet - 5mg